Stock SIMRIS B SIMRIS GROUP AB
Add to a list
To use this feature you must be a member
Log inSign up

Financials Simris Group AB

Equities

SIMRIS B

SE0008091664

Food Processing

Delayed Nasdaq Stockholm
Other stock markets
 06:01:51 2024-05-03 am EDT 		5-day change 1st Jan Change
0.117 SEK -6.02% Intraday chart for Simris Group AB -7.14% -48.00%
Apr. 15 Simris Group AB Enters into Amended Agreement to Extend the Term of the Flexible Funding Facility with The Brand Laboratories FZ CI
Mar. 14 Simris Group AB announced that it expects to receive ?1.15 million in funding from The Claremont Trust, Mountain High Trust, The Brand Laboratories FZE and other investors CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 64.66 36.64 56.32 58.12 45.35 78.32
Enterprise Value (EV) 1 65.93 33.48 43.8 60.29 43.48 75.32
P/E ratio -2.64 x -1.19 x -2.83 x -2.05 x -1.47 x -1.38 x
Yield - - - - - -
Capitalization / Revenue 84.9 x 21 x 24.7 x 9.13 x 11.1 x 18 x
EV / Revenue 86.5 x 19.2 x 19.2 x 9.47 x 10.7 x 17.3 x
EV / EBITDA -3.36 x -1.55 x -2.12 x -2.6 x -2.41 x -3.37 x
EV / FCF -4.69 x -4.41 x -2.3 x -12.1 x -2.92 x -3.27 x
FCF Yield -21.3% -22.7% -43.6% -8.29% -34.2% -30.6%
Price to Book 1.63 x 1.67 x 1.64 x 3.19 x 1.97 x 3.06 x
Nbr of stocks (in thousands) 13,444 13,470 57,004 78,547 180,303 348,071
Reference price 2 4.810 2.720 0.9880 0.7400 0.2515 0.2250
Announcement Date 4/16/19 5/12/20 4/16/21 4/20/22 4/17/23 4/17/24
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 0.7618 1.743 2.284 6.367 4.08 4.354
EBITDA 1 -19.62 -21.6 -20.66 -23.22 -18 -22.37
EBIT 1 -22.67 -24.63 -23.69 -26.14 -24.66 -36.64
Operating Margin -2,975.93% -1,412.85% -1,037.39% -410.48% -604.34% -841.41%
Earnings before Tax (EBT) 1 -23.99 -27.01 -25.54 -28.34 -25.77 -40.62
Net income 1 -23.97 -26.91 -25.6 -28.36 -24.42 -37.3
Net margin -3,146.57% -1,544% -1,121.02% -445.36% -598.58% -856.8%
EPS 2 -1.822 -2.287 -0.3489 -0.3610 -0.1715 -0.1632
Free Cash Flow 1 -14.05 -7.593 -19.08 -5 -14.89 -23.04
FCF margin -1,844.17% -435.65% -835.49% -78.54% -364.92% -529.27%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/16/19 5/12/20 4/16/21 4/20/22 4/17/23 4/17/24
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 1.27 - - 2.17 - -
Net Cash position 1 - 3.16 12.5 - 1.87 3
Leverage (Debt/EBITDA) -0.0647 x - - -0.0934 x - -
Free Cash Flow 1 -14 -7.59 -19.1 -5 -14.9 -23
ROE (net income / shareholders' equity) -58.1% -72% -62.1% -86.4% -118% -153%
ROA (Net income/ Total Assets) -27.2% -30.2% -27.1% -37.9% -14.3% -12.7%
Assets 1 88.16 89.21 94.46 74.88 170.3 293.5
Book Value Per Share 2 2.960 1.620 0.6000 0.2300 0.1300 0.0700
Cash Flow per Share 2 0.3300 0.3600 0.2100 0.0100 0.0200 0.0200
Capex 1 0.02 0.04 0.16 - 2.09 1.61
Capex / Sales 2.4% 2.12% 7.09% - 51.15% 37%
Announcement Date 4/16/19 5/12/20 4/16/21 4/20/22 4/17/23 4/17/24
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Special Foods & Wellbeing Products

1st Jan change Capi.
SIMRIS GROUP AB Stock Simris Group AB
-48.00% 3.97M
ZHEJIANG NHU COMPANY LTD. Stock Zhejiang NHU Company Ltd.
+13.21% 8.15B
BELLRING BRANDS, INC. Stock BellRing Brands, Inc.
-0.47% 7.49B
CSPC INNOVATION PHARMACEUTICAL CO., LTD. Stock CSPC Innovation Pharmaceutical Co., Ltd.
+12.30% 6.65B
BYHEALTH CO., LTD Stock Byhealth Co., Ltd
-6.99% 3.72B
THE SIMPLY GOOD FOODS COMPANY Stock The Simply Good Foods Company
-6.49% 3.7B
XIAMEN KINGDOMWAY GROUP COMPANY Stock Xiamen Kingdomway Group Company
-4.78% 1.31B
SIRIO PHARMA CO., LTD. Stock Sirio Pharma Co., Ltd.
+12.61% 972M
USANA HEALTH SCIENCES, INC. Stock USANA Health Sciences, Inc.
-12.13% 906M
HERBALIFE LTD. Stock Herbalife Ltd.
-38.53% 938M
Special Foods & Wellbeing Products
  1. Stock Market
  2. Equities
  3. SIMRIS B Stock
  4. Financials Simris Group AB